Duration of Benefit in Patients With Autoimmune Pulmonary Alveolar Proteinosis After Inhaled Granulocyte-Macrophage Colony-Stimulating Factor Therapy-Reference-Cited by-同舟云学术

Duration of Benefit in Patients With Autoimmune Pulmonary Alveolar Proteinosis After Inhaled Granulocyte-Macrophage Colony-Stimulating Factor Therapy

Published:2014-04 Issue:4 Volume:145 Page:729-737
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Tazawa Ryushi,Inoue Yoshikazu,Arai Toru,Takada Toshinori,Kasahara Yasunori,Hojo Masayuki,Ohkouchi Shinya,Tsuchihashi Yoshiko,Yokoba Masanori,Eda Ryosuke,Nakayama Hideaki,Ishii Haruyuki,Nei Takahito,Morimoto Konosuke,Nasuhara Yasuyuki,Ebina Masahito,Akira Masanori,Ichiwata Toshio,Tatsumi Koichiro,Yamaguchi Etsuro,Nakata Koh

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference27 articles.

1. Pulmonary alveolar proteinosis;Rosen;N Engl J Med,1958

2. Pulmonary alveolar proteinosis: progress in the first 44 years;Seymour;Am J Respir Crit Care Med,2002

3. Pulmonary alveolar proteinosis;Trapnell;N Engl J Med,2003

4. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor;Kitamura;J Exp Med,1999

5. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis;Uchida;Blood,2004

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Pulmonary Alveolar Proteinosis: A Review of Pathogenesis and Emerging Therapies;Current Pulmonology Reports;2024-05-16

2. Will inhalational GM-CSF replace whole lung lavage as a treatment for autoimmune pulmonary alveolar proteinosis? Many pole positions, not yet the final winner;European Respiratory Journal;2024-01

3. HLA-DRB1*14:54 Is Associated with Pulmonary Alveolar Proteinosis: A Retrospective Real-World Audit;Biomedicines;2023-10-27

4. Pulmonary alveolar proteinosis – current and future therapeutical strategies;Current Opinion in Pulmonary Medicine;2023-06-28

5. Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders;Frontiers in Immunology;2023-01-05